Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Cancer-Testis Antigen MAGE-C2/CT10 Promotes Proliferation and Enhances Resistance to p53 Mediated Apoptosis in Multiple Myeloma

Nesrine Lajmi, Julia Templin, Sara Yousef, Tim Luetkens, Stefanie Spock, York Hildebrandt, Katrin Bartels, Yanran Cao, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic

Blood (2012) 120 (21): 1808.

https://doi.org/10.1182/blood.V120.21.1808.1808

Published: 2012

Journal Articles

Prognostic Impact of Recipient and Donor CMV Serostatus in Acute Leukemia Patients After Allogeneic Stem Cell Transplantation At the Era of Preemptive Therapy.

Martin Schmidt-Hieber, Myriam Labopin, Dietrich Beelen, Liisa Volin, Gerhard Ehninger, Jürgen Finke, Gerard Socie, Rainer Schwerdtfeger, Nicolaus Kröger, Arnold Ganser, Dietger Niederwieser, Ulrike Feldmann, Carlheinz Müller, Emanuelle Polge, Igor Wolfgang Blau, Mohamad Mohty

Blood (2012) 120 (21): 3110.

https://doi.org/10.1182/blood.V120.21.3110.3110

Published: 2012

Journal Articles

Effective Prevention of Acute and Chronic Graft-Versus-Host Disease with Anti-Lymphocyte Globulin (ATG) without Increase of Relapse in HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation.

Nicolaus Kröger, Tatjana Zabelina, Francis Ayuk, Haefaa Alchalby, MD, Christine Wolschke, Thomas Stübig, Evgeny Klyuchnikov, Jürgen Berger, Axel R. Zander, MD

Blood (2012) 120 (21): 3055.

https://doi.org/10.1182/blood.V120.21.3055.3055

Published: 2012

Journal Articles

Impact of ASXL1 Mutations On Outcome After Reduced Intensity Allograft in Patients with Myelofibrosis

Nicolaus Kröger, Christian Koenecke, Haefaa Alchalby, MD, Tatjana Zabelina, MD, Robin Bollin, Marten Gehlhaar, Vera Dobbernack, Sofia Kade, Liu Huang, Arnold Ganser, Francis Ayuk, MD, Christine Wolschke, MD, Felicitas Thol, MD, Michael Heuser, MD

Blood (2012) 120 (21): 1740.

https://doi.org/10.1182/blood.V120.21.1740.1740

Published: 2012

Journal Articles

Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2012) 120 (21): 357.

https://doi.org/10.1182/blood.V120.21.357.357

Published: 2012

Journal Articles

Impact of Graft-Versus-Host Disease On Relapse After Allogeneic Hematopoietic Stem Cell Transplantation, an EBMT Megafile Study

Martin Stern, MD, Liesbeth C. de Wreede, PhD, Ronald Brand, PhD, Anja van Biezen, Peter Dreger, MD, Mohamad Mohty, MD, PhD, Theo M. de Witte, Nicolaus Kröger, Tapani Ruutu, MD, PhD

Blood (2012) 120 (21): 469.

https://doi.org/10.1182/blood.V120.21.469.469

Published: 2012

Journal Articles

Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation

Thomas Schroeder, MD, Julia Fröbel, Ron Patrick Cadeddu, Akos G. Czibere, MD, Ariane Dienst, Esther Zipperer, MD, Uwe Platzbecker, MD, Gesine Bug, Lutz Uharek, MD, Roland Fenk, MD, Ulrich Germing, Nicolaus Kröger, Rainer Haas, MD, Guido Kobbe, MD

Blood (2012) 120 (21): 1964.

https://doi.org/10.1182/blood.V120.21.1964.1964

Published: 2012

Journal Articles

Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party

Ali Bazarbachi, MD, PhD, Myriam Labopin, Mohamed A. Kharfan-Dabaja, MD, Gérard Socié, MD PhD, Nicolaus Kröger, Didier Blaise, MD, Hendrik Veelken, MD PhD, Arancha Bermudez, Reuven Or, MD, Bruno Lioure, MD, Dietrich Beelen, Nathalie Fegueux, MD, Rose-Marie Hamljadi, Arnon Nagler, Mohamad Mohty, MD, PhD

Blood (2012) 120 (21): 1929.

https://doi.org/10.1182/blood.V120.21.1929.1929

Published: 2012

Journal Articles

Post-Allogeneic Monitoring with Molecular Markers Detected by Pre-Transplant Next Generation Sequencing (NGS) Predicts Clinical Relapse in Patients with Chronic Myelomonocytic Leukemia (CMML)

Nicolaus Kröger, Thomas Schroeder, MD, Tatjana Zabelina, MD, Anita Badbaran, Ulrike Bacher, MD, Guido Kobbe, MD, Susanne Schnittger, PhD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 4212.

https://doi.org/10.1182/blood.V120.21.4212.4212

Published: 2012

Journal Articles

Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma

Roland Fenk, MD, Julia Baier, Aristoteles Giagounidis, MD, Mathias J. Rummel, MD, Nicolaus Kröger, Tobias Strapatsas, MD, Ariane Dienst, Esther Zipperer, MD, Kathrin Nachtkamp, MD, Alexander Burchardt, MD, Thomas Schroeder, MD, Lars Galonska, MD, Norbert Gattermann, MD, Rainer Haas, MD, Guido Kobbe, MD

Blood (2012) 120 (21): 1982.

https://doi.org/10.1182/blood.V120.21.1982.1982

Published: 2012

Journal Articles

Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT

Olle Ringden, MD PhD, Myriam Labopin, Hans Jochem Kolb, MD, Mauricette Michallet, MD, PhD, Nicolaus Kröger, Arnold Ganser, Donald Bunjes, Michael Hallek, MD, Lothar Kanz, MD, Rainer Schwerdtfeger, Ernst Holler, MD, Renate Arnold, MD, Anne Huynh, MD, Arnon Nagler, MD, Christoph Schmid, MD, PhD, Mohamad Mohty

Blood (2012) 120 (21): 2025.

https://doi.org/10.1182/blood.V120.21.2025.2025

Published: 2012

Journal Articles

Phase II Study of Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) As First Salvage Therapy in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Final Results From the AZARELA-Trial (NCT-00795548)

Thomas Schroeder, MD, Akos Czibere, MD, PhD, Nicolaus Kröger, Uwe Platzbecker, MD, Gesine Bug, Lutz Uharek, Prof., Dr., Thomas Luft, Christine Wolschke, Ingmar Bruns, MD, Fabian Zohren, MD, Roland Fenk, Rainer Haas, MD, Prof, Guido Kobbe, MD

Blood (2011) 118 (21): 656.

https://doi.org/10.1182/blood.V118.21.656.656

Published: 2011

Journal Articles

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

Blood (2011) 118 (21): 1019.

https://doi.org/10.1182/blood.V118.21.1019.1019

Published: 2011

Journal Articles

Donor Choice for Allogeneic Stem Cell Transplantation for AML – A Retrospective Single Centre Long-Term Analysis,

Francis Ayuk, MD, Friedericke Bernhardt, MD, Tatjana Zabelina, MD, Thomas Stübig, MD, Haefaa Alchalby, MD, Christine Wolschke, MD, Heinrich Lellek, MD, Ulrike Bacher, MD, Axel R. Zander, MD, Nicolaus Kröger

Blood (2011) 118 (21): 4147.

https://doi.org/10.1182/blood.V118.21.4147.4147

Published: 2011

Journal Articles

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Florent Malard, Nicolaus Kröger, Ian H Gabriel, Dr, Kai Hübel, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Rafael F. Duarte, MD, PhD, Mohamad Mohty

Blood (2011) 118 (21): 1932.

https://doi.org/10.1182/blood.V118.21.1932.1932

Published: 2011

Journal Articles

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Maximilian M Fresen, MD, Rafael F. Duarte, MD, PhD, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Ian H Gabriel, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Nicolaus Kröger, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Florian Lange, Mohamad Mohty, Kai Hübel, MD

Blood (2011) 118 (21): 2993.

https://doi.org/10.1182/blood.V118.21.2993.2993

Published: 2011

Journal Articles

Stem Cell Transplantation Can Provide Durable Disease Control in Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC): A Retrospective Study From the European Group for Blood and Marrow Transplantation (EBMT)

Blood (2011) 118 (21): 3077.

https://doi.org/10.1182/blood.V118.21.3077.3077

Published: 2011

Journal Articles

Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Eline Cremers, Anja van Biezen, StatAnalyst, Liesbeth C. de Wreede, PhD, Marijke Scholten, Antonin Vitek, Jürgen Finke, Uwe Platzbecker, MD, Dietrich Beelen, Rainer Schwerdtfeger, Liisa Volin, Nikolaos Harhalakis, Anton Schattenberg, Arnon Nagler, Theo de Witte, MD, PhD, Nicolaus Kröger

Blood (2011) 118 (21): 3014.

https://doi.org/10.1182/blood.V118.21.3014.3014

Published: 2011

Journal Articles

Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Nicolaus Kröger, Tatjana Zabelina, MD, Francis Ayuk, MD, Christine Wolschke, MD, Haefaa Alchalby, Anita Badbaran, Djordje Atanackovic, M.D., Georgia Schilling, MD, Orhan Sezer, MD, PhD, Ulrike Bacher, MD, Thomas Stübig, MD, Boris Fehse, Ph.D., Axel R. Zander, MD

Blood (2011) 118 (21): 148.

https://doi.org/10.1182/blood.V118.21.148.148

Published: 2011

Journal Articles

An Intergroup Randomised Trial of Standard Intensity Versus Reduced Intensity TBI-Based Conditioning In Patients with Acute Myeloid Leukemia in First Complete Remission

Blood (2011) 118 (21): 157.

https://doi.org/10.1182/blood.V118.21.157.157

Published: 2011

NARROW

Cancer-Testis Antigen MAGE-C2/CT10 Promotes Proliferation and Enhances Resistance to p53 Mediated Apoptosis in Multiple Myeloma

Prognostic Impact of Recipient and Donor CMV Serostatus in Acute Leukemia Patients After Allogeneic Stem Cell Transplantation At the Era of Preemptive Therapy.

Effective Prevention of Acute and Chronic Graft-Versus-Host Disease with Anti-Lymphocyte Globulin (ATG) without Increase of Relapse in HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation.

Impact of ASXL1 Mutations On Outcome After Reduced Intensity Allograft in Patients with Myelofibrosis

Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Graft-Versus-Host Disease On Relapse After Allogeneic Hematopoietic Stem Cell Transplantation, an EBMT Megafile Study

Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation

Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party

Post-Allogeneic Monitoring with Molecular Markers Detected by Pre-Transplant Next Generation Sequencing (NGS) Predicts Clinical Relapse in Patients with Chronic Myelomonocytic Leukemia (CMML)

Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma

Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

Donor Choice for Allogeneic Stem Cell Transplantation for AML – A Retrospective Single Centre Long-Term Analysis,

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Stem Cell Transplantation Can Provide Durable Disease Control in Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC): A Retrospective Study From the European Group for Blood and Marrow Transplantation (EBMT)

Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

An Intergroup Randomised Trial of Standard Intensity Versus Reduced Intensity TBI-Based Conditioning In Patients with Acute Myeloid Leukemia in First Complete Remission

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only